Dengue Virus Type 4 Envelope Antigen, Recombinant

Ref. 3D-CL6227

Informations sur le produit

• Nom: Dengue Virus Type 4 Envelope Antigen, Recombinant

Description

Dengue virus is a member of the Flaviviridae family and is responsible for causing dengue fever in humans. It is transmitted to humans primarily via the Aedes aegypti and Aedes albopicto female mosquitoes which acquire the virus while feeding on the blood of an infected person. Although this virus can inflict asymptomatic or mild symptoms in patients, it can lead to severe infectious such as dengue hemorrhagic fever, also known as dengue shock syndrome. The envelope protein, made up of the three domains I, II and III, plays a crucial role in host cell receptor-mediated endocytosis and fusion and is therefore an ideal target for neutralizing antibody formation. The global prevalence of dengue fever is significant and while there are numerous diagnostic tests on the market at present for dengue virus, there are few flavivirus panel assays and no specific dengue virus therapeutics available. Cymit Quimica’s biologics division is leading the field in the development of these target recombinant proteins and monoclonal antibodies. Our range of Dengue virus proteins and antibodies provides global development teams and researchers with access to vital and new raw material to test samples, in the race to diagnose patients earlier and help with vaccine development. We offer dengue virus proteins including envelope and NS1 from serotypes 1-4 and dengue virus monoclonal antibodies, for research and diagnostic purposes.

• Marque: Biosynth

Propriétés chimiques

• Degré de pureté: ≥95% On 12.5% By Sds-Page. Single Band Visible At Approximately 50 Kda.
• Couleur/Forme: Clear Liquid